Диссертация (1103954), страница 37
Текст из файла (страница 37)
Lipopolysaccharide endotoxins / R. Raetz, C. Whitfield // Annu. Rev. Biochem.— 2002. — Vol. 71. — P. 635–700.186[168] Nikaido, H. The outer membrane of Gram-negative bacteria / H. Nikaido, T. Nakae // Adv.Microb. Physiol. — 1980. — Vol. 20. — P. 163–250.[169] Takeuchi, O. Pattern recognition receptors and inflammation. / O Takeuchi, S Akira // Cell.— 2010. — Vol. 140. — P. 805–820.[170] Holst, O. Core oligosaccharide and lipid A components of lipopolysaccharides / O. Holst,A. Molinaro // Microbial glycobiology: structures relevance and applications / Ed.
byA Moran, P Brennan, O Holst, M von Itszstein. — San Diego : 2009. — P. 29–56.[171] Zahringer, U. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides / U. Zahringer, B. Lindner, E. Rietschel // Adv. Carbohydr. Chem. Biochem. —1994. — Vol.
50. — P. 211–276.[172] Brandenburg, K. Endotoxins: relationships between structure, function, and activity /K. Brandenburg, A. Wiese // Curr. Top. Med. Chem. — 2004. — Vol. 4, no. 11.— P. 1127–1146.[173] Wang, X. Endotoxins:lipopolysaccharides of gram-negative bacteria / X. Wang,P. J. Quinn // Subcell. Biochem. — 2010. — Vol. 53. — P.
3–25.[174] Bacterial lipopolysaccharides: structure, chemical synthesis, biogenesis and interactionwith host cells / Ed. by Yu. Knirel, M. Valvano. — Springer edition. — 2011. —ISBN: 9783709107324.[175] Книрель, Ю. А. Строение липополисахаридов грамотрицательных бактерий. II.
Структура кора. / Ю. А. Книрель, Н. К. Кочетков // Биохимия. — 1993. — Т. 58, № 2. —С. 182–220.[176] Holst, O. Endotoxin in health and disease / O. Holst. — 1999. — ISBN: 0824719441.[177] Nikaido, H. Role of permeability barriers in resistance to b-lactam antibiotics. / H. Nikaido //Pharmacol. Ther. — 1985.
— Vol. 27. — P. 197–231.[178] Nikaido, H. Preventing drug access to targets: cell surface permeability barriers and activeefflux in bacteria / H. Nikaido // Semin. Cell. Dev. Biol. — 2001. — Vol. 12, no. 3. —P. 215–223.[179] Книрель, Ю. А. Строение липополисахаридов грамотрицательных бактерий. III.Структура О-специфических полисахаридов / Ю. А. Книрель, Н. К. Кочетков // Биохимия. — 1994. — Т. 59, № 12. — С. 1784–1851.187[180] Wang, L. The variation of O antigens in gram-negative bacteria / L.
Wang, Q. Wang,P. R. Reeves // Subcell. Biochem. — 2010. — Vol. 53. — P. 123–152.[181] Hölzer, S. Effect of the O-antigen length of lipopolysaccharide on the functions of type IIIsecretion systems in Salmonella enterica / S Hölzer, M Schlumberger, D Jäckel, M Hensel //Infect. Immun. — 2009. — Vol. 77, no. 12. — P. 5458–5470.[182] Lerouge, I. O-antigen structural variation: mechanisms and possible roles in animal/plantmicrobe interactions / I.
Lerouge, J. Vanderleyden // FEMS Microbiol. Rev. — 2001. —Vol. 26. — P. 17–47.[183] Walker, S. L. Role of cell surface lipopolysaccharides in Escherihia coli K12 adhesion andtransport / S. L. Walker, J. A. Redman, M. Elimelech // Langmuir. — 2004.
— no. 24.— P. 7736–7746.[184] Wang, W. Method of X-ray anomalous diffraction for lipid structures / W. Wang, D. Pan,Y. Song, et al. // Biophys. J. — 2006. — Vol. 91, no. 2. — P. 736–743.[185] Zeuke, S. TLR4-mediated inflammatory activation of human coronary artery endothelialcells by LPS / S. Zeuke, A. J. Ulmer, S. Kusumoto, et al.
// Cardiovasc. Res. — 2002. —Vol. 56, no. 1. — P. 126–134.[186] Sabroe, I. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: acritical role for monocytes in leukocyte lipopolysaccharide responses / I. Sabroe, E. C. Jones,L. R. Usher, et al. // J. Immunol. — 2002. — Vol. 168, no. 9. — P. 4701–4710.[187] Poltorak, A. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations inTlr4 gene / A. Poltorak, X. He, I. Smirnova, et al. // Science.
— 1998. — Vol. 282. —P. 2085–2088.[188] Park, B. S. Recognition of lipopolysaccharide pattern by TLR4 complexes / B. S. Park,J. O. Lee // Exp. Mol. Med. — 2013. — Vol. 45. — P. e66.[189] Wright, S. D. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS bindingprotein / S. D. Wright, R. A. Ramos, P.
S. Tobias, et al. // Science. — 1990. — Vol. 249.— P. 1431–1433.[190] Shimazu, R. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-likereceptor 4 / R. Shimazu, S. Akashi, H. Ogata, et al. // J. Exp. Med. — 1999. — Vol. 189.— P. 1777–1782.188[191] Mueller, M. Endotoxin: physical requirements for cell activation / M. Mueller, B. Lindner,R. Dedrick, et al. // J. Endotoxin. Res. — 2005. — Vol. 11, no. 5. — P. 299–303.[192] Gutsmann, T.
The physicochemistry of endotoxins in relation to bioactivity / T. Gutsmann,A. B. Schromm, K. Brandenburg // Int. J. Med. Microbiol. — 2007. — Vol. 297, no. 5.— P. 341–352.[193] Lynn, W. A. Neither CD14 nor serum is absolutely necessary for activation of mononuclearphagocytes by bacterial lipopolysaccharide / W. A. Lynn, Y.
Liu, D. T. Golenbock // Infect.Immun. — 1993. — Vol. 61. — P. 4452–4461.[194] Gangloff, S. C. Lipopolysaccharide structure influences the macrophage response via CD14independent and CD14-dependent pathways. / S. C. Gangloff, N. Hijiya, A. Haziot,S. M. Goyert // Clin. Infect. Dis. — 1999. — Vol. 28. — P. 491–496.[195] Seydel, U. Intrinsic conformation of lipid A is responsible for agonistic and antagonisticactivity / U. Seydel, M. Oikawa, K. Fukase, et al. // Eur. J. Biochem. — 2000. — Vol.267, no. 10.
— P. 3032–3039.[196] Seydel, U. The generalized endotoxic principle / U. Seydel, L. Hawkins, A. B. Schromm,et al. // Eur. J. Immunol. — 2003. — Vol. 33, no. 6. — P. 1586–1592.[197] Brandenburg, K. Influence of the supramolecular structure of free lipid A on its biologicalactivity / K. Brandenburg, H.
Mayer, M. H. J. Koch, et al. // Eur. J. Biochem. — 1993.— Vol. 218, no. 2. — P. 555–563.[198] Fukuoka, S. Physico-chemical analysis of lipid A fractions of lipopolysaccharide from Erwiniacarotovora in relation to bioactivity / S. Fukuoka, K. Brandenburg, M. Muller, et al. //Biochim. Biophys. Acta. — 2001. — Vol. 1510. — P. 185–197.[199] Oikawa, M.
NMR conformational analysis of biosynthetic precursor-type lipid A:monomolecular state and supramolecular assembly / M. Oikawa, T. Shintaku, N. Fukuda,et al. // Org. Biomol. Chem. — 2004. — Vol. 2. — P. 3557–3565.[200] Brandenburg, K. Physicochemical properties of bacterial glycopolymers in relation to bioactivity / K. Brandenburg, J. Andrä, M. Müller, et al. // Carbohydr. Res. — 2003. — Vol.338, no. 23.
— P. 2477–2489.[201] D’Errico, G. Mesoscopic and microstructural characterization of liposomes formed by thelipooligosaccharide from Salmonella minnesota strain 595 (Re mutant) / G. D’Errico,189A. Silipo, G. Mangiapia, et al. // Phys. Chem. Chem. Phys. — 2009. — Vol. 11,no. 13. — P. 2314–2322.[202] Kim, J. I. Crystal structure of CD14 and its implications for lipopolysaccharide signaling /J. I. Kim, J. L. Chang, S. J. Mi, et al. // J. Biol. Chem.
— 2005. — Vol. 280, no. 12. —P. 11347–11351.[203] Boutet, J. Detailed investigation of the immunodominant role of O-antigen stoichiometricO-acetylation as revealed by chemical synthesis, immunochemistry, solution conformationand STD-NMR spectroscopy for Shigella flexneri 3a / J. Boutet, P. Blasco, C. Guerreiro,et al. // Chemistry. — 2016. — Vol. 22, no.
31. — P. 10892–10911.[204] D’Errico, G. Characterization of liposomes formed by lipopolysaccharides from Burkholderiacenocepacia, Burkholderia multivorans and Agrobacterium tumefaciens: from the molecularstructure to the aggregate architecture / G. D’Errico, A. Silipo, G. Mangiapia, et al. //Phys. Chem.
Chem. Phys. — 2010. — Vol. 12, no. 41. — P. 13574–13585.[205] Vanderley, P. O-antigenic chains of lipopolysaccharide prevent binding of antibody moleculesto an outer-membrane pore protein in enterobacteriaceae / P. Vanderley, O. Kuipers, J. Tommassen, B. Lugtenberg // Microb. Pathog. — 1986. — Vol. 1. — P. 43–49.[206] Bentley, A. T. Effect of lipopolysaccharide structure on reactivity of antiporin monoclonalantibodies with the bacterial cell surface / A. T. Bentley, P. E.
Klebba // J. Bacteriol. —1988. — Vol. 170. — P. 1063–1068.[207] Normark, S. A pathogen attacks while keeping up defense / S. Normark, C. Nilsson,B. H. Normark // Science. — 2005. — Vol. 307. — P. 1211–1212.[208] West, N. P. Optimization of virulence functions through glucosylation of Shigella LPS /N. P. West, P. Sansonetti, J. Mounier, et al. // Science. — 2005. — Vol. 307, no. 5713.— P. 1313–1317.[209] Bock, K. Lipopolysaccharide solution conformation: antigen shape inferred from high resolution 1H and 13C nuclear magnetic resonance spectroscopy and hard-sphere calculations /K.
Bock, S. Josephson, D. R. Bundle // J. Chem. Soc., Perkin Transactions 2. — 1982. —Vol. 0. — P. 59–70.190[210] Knirel, Y. A. Variations in O-antigen biosynthesis and O-acetylation associated with alteredphage sensitivity in Escherichia coli 4s / Y. A. Knirel, N. S. Prokhorov, A. S. Shashkov,et al. // J. Bacteriol. — 2014. — Vol. 197, no. 5.
— P. 905–912.[211] Naumann, D. New insights into the phase behaviour of a complex anionic amphiphile: architecture and dynamics of bacterial deep rough lipopolysaccharide membranes as seen byFTIR, X-Ray, and moleculalr modelling techniques / D. Naumann, C. Schultz, C. Sabisch,et al. // J. Mol. Struct. — 1989. — Vol. 214. — P. 213–246.[212] Glauert, A. M. The topography of the bacterial cell wall / A.
M. Glauert, M. J. Thornley //Ann. Rev. Microbiol. — 1969. — Vol. 23. — P. 159–198.[213] Amro, N. High-resolution atomic force microscopy studies of the Escherichia coli outer membrane: structural basis for permeability / N. Amro, L. Kotra, K.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
